Healthcare provider profile · identity verified

Raza Ali, M.D

Family Practice · CANTON, MI · NPI 1417245515

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	170
Amlodipine Besylate	Amlodipine Besylate	357	101
Lisinopril	Lisinopril	287	78
Levothyroxine Sodium	Levothyroxine Sodium	275	69
Omeprazole	Omeprazole	272	82
Gabapentin	Gabapentin	259	57
Losartan Potassium	Losartan Potassium	240	76
Metformin Hcl	Metformin Hcl	198	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	197	48
Olmesartan Medoxomil	Olmesartan Medoxomil	146	38
Hydrochlorothiazide	Hydrochlorothiazide	138	44
Metoprolol Succinate	Metoprolol Succinate	136	41
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	124	66
Pregabalin	Pregabalin	124	32
Furosemide	Furosemide	123	43
Meloxicam	Meloxicam	123	50
Tamsulosin Hcl	Tamsulosin Hcl	120	44
Metoprolol Tartrate	Metoprolol Tartrate	110	30
Pantoprazole Sodium	Pantoprazole Sodium	103	30
Celecoxib	Celecoxib	101	29
Simvastatin	Simvastatin	101	31
Pravastatin Sodium	Pravastatin Sodium	94	28
Eliquis	Apixaban	88	26
Sertraline Hcl	Sertraline Hcl	88	24
Doxepin Hcl	Doxepin Hcl	83	17
Bupropion Xl	Bupropion Hcl	82	18
Carvedilol	Carvedilol	81	23
Allopurinol	Allopurinol	76	22
Albuterol Sulfate Hfa	Albuterol Sulfate	73	28
Trazodone Hcl	Trazodone Hcl	63	23
Rosuvastatin Calcium	Rosuvastatin Calcium	61	22
Zolpidem Tartrate	Zolpidem Tartrate	61	suppressed
Baclofen	Baclofen	58	24
Famotidine	Famotidine	55	19
Tizanidine Hcl	Tizanidine Hcl	54	15
Buspirone Hcl	Buspirone Hcl	51	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	51	47
Clopidogrel	Clopidogrel Bisulfate	50	15
Citalopram Hbr	Citalopram Hydrobromide	47	12
Alprazolam	Alprazolam	46	16
Ibuprofen	Ibuprofen	43	18
Fluticasone Propionate	Fluticasone Propionate	42	19
Ventolin Hfa	Albuterol Sulfate	42	suppressed
Atenolol	Atenolol	41	13
Chlorthalidone	Chlorthalidone	41	13
Glipizide	Glipizide	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	16
Mirtazapine	Mirtazapine	40	12
Clonazepam	Clonazepam	38	16
Donepezil Hcl	Donepezil Hcl	38	11
Potassium Chloride	Potassium Chloride	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	37	13
Jardiance	Empagliflozin	37	12
Metformin Hcl Er	Metformin Hcl	36	11
Alendronate Sodium	Alendronate Sodium	35	12
Tramadol Hcl	Tramadol Hcl	35	suppressed
Glimepiride	Glimepiride	34	11
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Glipizide Er	Glipizide	33	suppressed
Prednisone	Prednisone	31	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	14
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	11
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Valsartan	Valsartan	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Primidone	Primidone	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Diazepam	Diazepam	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Cephalexin	Cephalexin	18	14
Lovastatin	Lovastatin	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Finasteride	Finasteride	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Bumetanide	Bumetanide	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	12
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Torsemide	Torsemide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Colchicine	Colchicine	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Azithromycin	Azithromycin	11	11
Benazepril Hcl	Benazepril Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error